Studying self-sampling and digital colposcopy to prioritize women at cervical cancer risk
Looks at self-sampling tests and remote colposcopy to decide which women need prompt cervical checks.
Plain-language title generated from the registry record
Registry title: PRIORITY Study in Cervical Cancer
Key facts
- Where
- Coquimbo, Coyhaique, Santiago, and Talca, ChileSee the 8 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 30 to 65 who can take part in cervical cancer screening. It tests a new way to prioritise care using self-sampling and digital colposcopy.
- Age
- 30 to 65 years
- Sex
- Women only
Main reasons for not taking part
- Previous diagnosis of cervical cancer
- Total hysterectomy (cervix removed)
- Current pregnancy, if it prevents study procedures according to clinical judgment
- Any medical or social condition that would interfere with taking part or follow-up
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 65 years old?
Source: NCT07593066, who can take part
Where in Chile
- Hospital San PabloCoquimbo, ChileContact: Pablo Avalos, MDNo longer taking part
- Hospital regional de CoyhaiqueCoyhaique, ChileContact: Pablo Mardones, MDNo longer taking part
- Ancora San Francisco Medical Center UC Christus Health NetworkSantiago, ChileContact: Nicolás Saez, MDNo longer taking part
- Cancer Centre UC-Christus Nuestra Sra de la EsperanzaSantiago, ChileContact: Mauricio A Cuello, MDNo longer taking part
- San Joaquín Medical Center, UCChristus Health NetworkSantiago, ChileContact: Nicolas Saez, MDNo longer taking part
- San Jorge Medical Center UC-Christus Health NetworkSantiago, ChileContact: Nicolas A Saez, MDNo longer taking part
- Santa Lucia Medical Center UC-Christus Health NetworkSantiago, ChileContact: Nicolas Saez, MDNo longer taking part
- Hospital de TalcaTalca, ChileContact: Yesica Sagredo, MDNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Pontificia Universidad Catolica de Chile
- Trial code
- NCT07593066
- Record updated
- 18 May 2026
- Original description
The PRIORITY study is a prospective, multicenter observational study designed to evaluate an integrated diagnostic model combining extended molecular self-sampling and digital colposcopy supported by telemedicine for the prioritization of women at risk of cervical cancer.Read full original descriptionShow less
The PRIORITY Study in Cervical Cancer: A Prospective Multicenter Observational Evaluation of an Integrated Molecular and Digital Model for Diagnostic Prioritization
The PRIORITY study is a prospective, multicenter observational study designed to evaluate an integrated diagnostic model combining extended molecular self-sampling and digital colposcopy supported by telemedicine for the prioritization of women at risk of cervical cancer.
The study aims to assess the diagnostic performance, concordance, and clinical utility of this integrated approach in real-world settings, as well as its impact on diagnostic timeliness and patient navigation across different levels of care.
Participants will undergo standard-of-care evaluation, and data will be collected on molecular test results, colposcopic findings, diagnostic outcomes, and time intervals within the care pathway. No interventions are assigned as part of the study protocol.
The findings are expected to inform scalable strategies to improve early detection and optimize diagnostic pathways for cervical cancer, particularly in settings with structural and geographic barriers to timely care.
Inclusion: Women aged 30 to 65 years; Eligible for cervical cancer screening according to national guidelines; Able and willing to provide informed consent; Able to perform self-sampling or attend clinical evaluation if required.
Exclusion: Previous diagnosis of cervical cancer; History of total hysterectomy (removal of the cervix); Any medical or social condition that, in the opinion of the investigators, would interfere with participation or follow-up; Current pregnancy if it precludes study procedures according to clinical judgment.